Skip to main content
Top
Published in: Lasers in Medical Science 2/2014

01-03-2014 | Original Article

A 635-nm light-emitting diode (LED) therapy inhibits bone resorptive osteoclast formation by regulating the actin cytoskeleton

Authors: Hyun-Ju Lim, Man-Seok Bang, Hye-Min Jung, Jang-In Shin, Gae-Sig Chun, Chung-Hun Oh

Published in: Lasers in Medical Science | Issue 2/2014

Login to get access

Abstract

Bone diseases such as osteoporosis are mainly caused by upregulated activity of osteoclasts. The present study was designed to examine the effects of light-emitting diode (LED) irradiation on the formation and activity of multinucleated osteoclasts, specifically “round-shaped” osteoclast cells (ROC) in different cell types derived from mouse. After 635-nm LED irradiation, the cell viability was evaluated by MTT assay. The amount of total tartrate-resistant acid phosphatase (TRAP) + osteoclast and the number of ROC cells were also estimated by TRAP solution assay and TRAP staining, respectively. Actin rings were stained with rhodamine-conjugated phalloidin, and resorption assay was performed by dentin slices. In addition, gene expression levels between the control and irradiation groups were evaluated by RT-PCR. In a morphological analysis, the formation of ROC was significantly inhibited by 635-nm LED irradiation in the different cell types. Actin rings were seen at cell peripheries in most ROC cells of the control group, but patches containing disorganized actin were found in the irradiation group. Both the number of ROCs and bone resorption activity were much lower in the irradiation group than in the control group. Also, the gene expression levels involved in actin ring formation such as integrin β3 and c-Src decreased in RT-PCR analysis. Overall, 635-nm LED therapy may play a pivotal role in regulating bone remodeling, and it may prove to be a valuable tool to prevent bone loss in osteoporosis and other resorptive bone diseases.
Literature
1.
go back to reference Eriksen EF. Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 11:219–27. Eriksen EF. Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 11:219–27.
2.
go back to reference Honig S. Osteoporosis - new treatments and updates. Bull NYU Hosp Jt Dis 69:253–6. Honig S. Osteoporosis - new treatments and updates. Bull NYU Hosp Jt Dis 69:253–6.
3.
go back to reference Toumba M, Skordis N. Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos 2010:537673. Toumba M, Skordis N. Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos 2010:537673.
4.
go back to reference Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765PubMedCrossRef Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765PubMedCrossRef
5.
go back to reference Barrett-Connor E, Mosca L, Collins P et al (2006) Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355:125–137PubMedCrossRef Barrett-Connor E, Mosca L, Collins P et al (2006) Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 355:125–137PubMedCrossRef
6.
go back to reference Rizzoli R, Burlet N, Cahall D et al (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42:841–847PubMedCrossRef Rizzoli R, Burlet N, Cahall D et al (2008) Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 42:841–847PubMedCrossRef
7.
go back to reference Yavropoulou MP, Yovos JG (2008) Osteoclastogenesis: current knowledge and future perspectives. J Musculoskelet Neuronal Interact 8:204–216PubMed Yavropoulou MP, Yovos JG (2008) Osteoclastogenesis: current knowledge and future perspectives. J Musculoskelet Neuronal Interact 8:204–216PubMed
8.
go back to reference Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638–649PubMedCrossRef Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638–649PubMedCrossRef
9.
go back to reference Fujii H, Cody SH, Seydel U et al (1997) Recording of mitochondrial transmembrane potential and volume in cultured rat osteoclasts by confocal laser scanning microscopy. Histochem J 29:571–581PubMedCrossRef Fujii H, Cody SH, Seydel U et al (1997) Recording of mitochondrial transmembrane potential and volume in cultured rat osteoclasts by confocal laser scanning microscopy. Histochem J 29:571–581PubMedCrossRef
10.
go back to reference Asotra S, Gupta AK, Sodek J et al (1994) Carbonic anhydrase II mRNA expression in individual osteoclasts under "resorbing" and "nonresorbing" conditions. J Bone Miner Res 9:1115–1122PubMedCrossRef Asotra S, Gupta AK, Sodek J et al (1994) Carbonic anhydrase II mRNA expression in individual osteoclasts under "resorbing" and "nonresorbing" conditions. J Bone Miner Res 9:1115–1122PubMedCrossRef
11.
go back to reference Kanehisa J, Heersche JN (1988) Osteoclastic bone resorption: in vitro analysis of the rate of resorption and migration of individual osteoclasts. Bone 9:73–79PubMedCrossRef Kanehisa J, Heersche JN (1988) Osteoclastic bone resorption: in vitro analysis of the rate of resorption and migration of individual osteoclasts. Bone 9:73–79PubMedCrossRef
12.
go back to reference Krynicka I, Rutowski R, Staniszewska-Kus J (2010) The role of laser biostimulation in early postsurgery rehabilitation and its effect on wound healing. Ortop Traumatol Rehabil 12(1):67–79PubMed Krynicka I, Rutowski R, Staniszewska-Kus J (2010) The role of laser biostimulation in early postsurgery rehabilitation and its effect on wound healing. Ortop Traumatol Rehabil 12(1):67–79PubMed
13.
go back to reference AlGhamdi KM, Kumar A, Moussa NA (2011) Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells. Lasers Med Sci 27(1):237–249PubMedCrossRef AlGhamdi KM, Kumar A, Moussa NA (2011) Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells. Lasers Med Sci 27(1):237–249PubMedCrossRef
14.
go back to reference Fujimoto K, Kiyosaki T, Mitsui N (2010) Low-intensity laser irradiation stimulates mineralization via increased BMPs in MC3T3-E1 cells. Lasers Surg Med 42(6):519–526PubMedCrossRef Fujimoto K, Kiyosaki T, Mitsui N (2010) Low-intensity laser irradiation stimulates mineralization via increased BMPs in MC3T3-E1 cells. Lasers Surg Med 42(6):519–526PubMedCrossRef
15.
go back to reference Kim YD, Kim SS, Kim SJ (2010) Low-level laser irradiation facilitates fibronectin and collagen type I turnover during tooth movement in rats. Lasers Med Sci 25(1)):25–31PubMedCrossRef Kim YD, Kim SS, Kim SJ (2010) Low-level laser irradiation facilitates fibronectin and collagen type I turnover during tooth movement in rats. Lasers Med Sci 25(1)):25–31PubMedCrossRef
16.
go back to reference Stein A, Benayahu D, Maltz L, Oron U (2005) Low-level laser irradiation promotes proliferation and differentiation of human osteoblasts in vitro. Photomed Laser Surg 23:161–166PubMedCrossRef Stein A, Benayahu D, Maltz L, Oron U (2005) Low-level laser irradiation promotes proliferation and differentiation of human osteoblasts in vitro. Photomed Laser Surg 23:161–166PubMedCrossRef
17.
go back to reference Vinck EM, Cagnie BJ, Cornelissen MJ et al (2003) Increased fibroblast proliferation induced by light emitting diode and low power laser irradiation. Lasers Med Sci 18:95–99PubMedCrossRef Vinck EM, Cagnie BJ, Cornelissen MJ et al (2003) Increased fibroblast proliferation induced by light emitting diode and low power laser irradiation. Lasers Med Sci 18:95–99PubMedCrossRef
18.
go back to reference Volpato LE, de Oliveira RC, Espinosa MM et al. Viability of fibroblasts cultured under nutritional stress irradiated with red laser, infrared laser, and red light-emitting diode. J Biomed Opt 16:075004. Volpato LE, de Oliveira RC, Espinosa MM et al. Viability of fibroblasts cultured under nutritional stress irradiated with red laser, infrared laser, and red light-emitting diode. J Biomed Opt 16:075004.
19.
go back to reference Tintut Y, Parhami F, Tsingotjidou A et al (2002) 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277:14221–14226PubMedCrossRef Tintut Y, Parhami F, Tsingotjidou A et al (2002) 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 277:14221–14226PubMedCrossRef
20.
go back to reference Ostrov DA, Magis AT, Wronski TJ et al (2009) Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening. J Med Chem 52:5144–5151PubMedCentralPubMedCrossRef Ostrov DA, Magis AT, Wronski TJ et al (2009) Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening. J Med Chem 52:5144–5151PubMedCentralPubMedCrossRef
21.
go back to reference de Souza Faloni AP, Schoenmaker T, Azari A (2011)) Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int 88(1):63–74PubMedCentralPubMedCrossRef de Souza Faloni AP, Schoenmaker T, Azari A (2011)) Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int 88(1):63–74PubMedCentralPubMedCrossRef
22.
go back to reference Aihara N, Yamaguchi M, Kasai K (2006) Low-energy irradiation stimulates formation of osteoclast-like cells via RANK expression in vitro. Lasers Med Sci 21:24–33PubMedCrossRef Aihara N, Yamaguchi M, Kasai K (2006) Low-energy irradiation stimulates formation of osteoclast-like cells via RANK expression in vitro. Lasers Med Sci 21:24–33PubMedCrossRef
23.
go back to reference Ninomiya T, Hosoya A, Nakamura H et al (2007) Increase of bone volume by a nanosecond pulsed laser irradiation is caused by a decreased osteoclast number and an activated osteoblasts. Bone 40:140–148PubMedCrossRef Ninomiya T, Hosoya A, Nakamura H et al (2007) Increase of bone volume by a nanosecond pulsed laser irradiation is caused by a decreased osteoclast number and an activated osteoblasts. Bone 40:140–148PubMedCrossRef
24.
go back to reference Bouvet-Gerbettaz S, Merigo E, Rocca JP et al (2009) Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts. Lasers Surg Med 41:291–297PubMedCrossRef Bouvet-Gerbettaz S, Merigo E, Rocca JP et al (2009) Effects of low-level laser therapy on proliferation and differentiation of murine bone marrow cells into osteoblasts and osteoclasts. Lasers Surg Med 41:291–297PubMedCrossRef
25.
go back to reference Hawkins DH, Abrahamse H (2006) The role of laser fluence in cell viability, proliferation, and membrane integrity of wounded human skin fibroblasts following helium–neon laser irradiation. Lasers Surg Med 38:74–83PubMedCrossRef Hawkins DH, Abrahamse H (2006) The role of laser fluence in cell viability, proliferation, and membrane integrity of wounded human skin fibroblasts following helium–neon laser irradiation. Lasers Surg Med 38:74–83PubMedCrossRef
26.
go back to reference Ohara M, Kawashima Y, Katoh O, Watanabe H (2002) Blue light inhibits the growth of B16 melanoma cells. Jpn J Cancer Res 93:551–558PubMedCrossRef Ohara M, Kawashima Y, Katoh O, Watanabe H (2002) Blue light inhibits the growth of B16 melanoma cells. Jpn J Cancer Res 93:551–558PubMedCrossRef
27.
go back to reference Gorgidze LA, Oshemkova SA, Vorobjev IA (1998) Blue light inhibits mitosis in tissue culture cells. Biosci Rep 18:215–224PubMedCrossRef Gorgidze LA, Oshemkova SA, Vorobjev IA (1998) Blue light inhibits mitosis in tissue culture cells. Biosci Rep 18:215–224PubMedCrossRef
28.
go back to reference Wataha JC, Lewis JB, Lockwood PE et al (2004) Blue light differentially modulates cell survival and growth. J Dent Res 83:104–108PubMedCrossRef Wataha JC, Lewis JB, Lockwood PE et al (2004) Blue light differentially modulates cell survival and growth. J Dent Res 83:104–108PubMedCrossRef
29.
go back to reference Pflaum M, Kielbassa C, Garmyn M, Epe B (1998) Oxidative DNA damage induced by visible light in mammalian cells: extent, inhibition by antioxidants, and genotoxic effects. Mutat Res 408:137–146PubMedCrossRef Pflaum M, Kielbassa C, Garmyn M, Epe B (1998) Oxidative DNA damage induced by visible light in mammalian cells: extent, inhibition by antioxidants, and genotoxic effects. Mutat Res 408:137–146PubMedCrossRef
30.
go back to reference Kollet O, Canaani J, Kalinkovich A, Lapidot T (2012)) Regulatory cross talks of bone cells, hematopoietic stem cells, and the nervous system maintain hematopoiesis. Inflamm Allergy Drug Targets 11(3):170–180PubMedCrossRef Kollet O, Canaani J, Kalinkovich A, Lapidot T (2012)) Regulatory cross talks of bone cells, hematopoietic stem cells, and the nervous system maintain hematopoiesis. Inflamm Allergy Drug Targets 11(3):170–180PubMedCrossRef
31.
go back to reference Sul OJ, Ke K, Kim WK (2012) Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation. J Cell Physiol 227((4):1619–1627CrossRef Sul OJ, Ke K, Kim WK (2012) Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation. J Cell Physiol 227((4):1619–1627CrossRef
32.
go back to reference Tomomura M, Hasegawa H, Suda N (2012)) Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-kappaB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway. J Biol Chem 287(22):17963–17974PubMedCentralPubMedCrossRef Tomomura M, Hasegawa H, Suda N (2012)) Serum calcium-decreasing factor, caldecrin, inhibits receptor activator of NF-kappaB ligand (RANKL)-mediated Ca2+ signaling and actin ring formation in mature osteoclasts via suppression of Src signaling pathway. J Biol Chem 287(22):17963–17974PubMedCentralPubMedCrossRef
33.
go back to reference Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342PubMedCrossRef Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342PubMedCrossRef
34.
go back to reference Negishi-Koga T, Takayanagi H (2009) Ca2 + −NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev 231:241–256PubMedCrossRef Negishi-Koga T, Takayanagi H (2009) Ca2 + −NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol Rev 231:241–256PubMedCrossRef
35.
go back to reference Zou W, Kitaura H, Reeve J et al (2007) Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol 176:877–888PubMedCentralPubMedCrossRef Zou W, Kitaura H, Reeve J et al (2007) Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol 176:877–888PubMedCentralPubMedCrossRef
36.
37.
go back to reference Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702PubMedCrossRef Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702PubMedCrossRef
38.
go back to reference McHugh KP, Hodivala-Dilke K, Zheng MH et al (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433–440PubMedCentralPubMedCrossRef McHugh KP, Hodivala-Dilke K, Zheng MH et al (2000) Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105:433–440PubMedCentralPubMedCrossRef
39.
go back to reference Biskobing DM, Fan D (2000) Acid pH increases carbonic anhydrase II and calcitonin receptor mRNA expression in mature osteoclasts. Calcif Tissue Int 67:178–183PubMedCrossRef Biskobing DM, Fan D (2000) Acid pH increases carbonic anhydrase II and calcitonin receptor mRNA expression in mature osteoclasts. Calcif Tissue Int 67:178–183PubMedCrossRef
40.
go back to reference Wada S, Udagawa N, Akatsu T et al (1997) Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology 138:521–529PubMed Wada S, Udagawa N, Akatsu T et al (1997) Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology 138:521–529PubMed
Metadata
Title
A 635-nm light-emitting diode (LED) therapy inhibits bone resorptive osteoclast formation by regulating the actin cytoskeleton
Authors
Hyun-Ju Lim
Man-Seok Bang
Hye-Min Jung
Jang-In Shin
Gae-Sig Chun
Chung-Hun Oh
Publication date
01-03-2014
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 2/2014
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-013-1363-9

Other articles of this Issue 2/2014

Lasers in Medical Science 2/2014 Go to the issue